Recreating key features of the antibody factory in a dish
FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Atopic dermatitis trial meets primary endpoint
Key to immunotherapy for intractable brain tumours discovered
Fast Track Designation for colorectal cancer treatment
AI helps predict which DNA sequences bind to each other
Boost for Niagen’s NAD+ programme
Base to Base biotech podcast 68: Water from air for pharma and beyond
New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing